Why was the infant-formula botulism outbreak declared over?

Public health authorities say the immediate threat has passed

The U.S. Centers for Disease Control and Prevention has declared the botulism outbreak tied to infant formula over, even as federal investigators continue probing its root cause. The declaration reflects that investigators found no new linked cases over the interval they monitor for outbreak recurrence, and that active case-counts have fallen to a level consistent with the end of an outbreak phase.

The conclusion of the acute outbreak phase does not close the broader investigation. Agencies and manufacturers remain focused on pinpointing how contamination occurred and whether a single source or a production step was responsible. In parallel, some regulators outside the U.S. have taken action on specific ingredients connected to earlier problems: the European Union has tightened import controls on an arachidonic acid oil from China that regulators say was linked to contamination concerns in some formulas.

What happens next

• Continued federal and industry investigations to identify the contamination pathway and any manufacturing or supply-chain failures.
• Potential targeted recalls or reformulations depending on what the investigations find.
• Regulatory reviews and tightened import or testing requirements for implicated ingredients.

Why it matters

Parents and caregivers rely on clear signals about product safety. Even though the outbreak has been declared over, the ongoing probes will determine whether further consumer actions, recalls, or regulatory changes are needed to prevent a recurrence. The episode has already prompted industrywide scrutiny of ingredient sourcing and quality-control practices, and it has accelerated regulatory conversations in multiple jurisdictions about stronger oversight for infant-formula inputs.